Literature DB >> 29721548

Nrf2 Deficiency Promotes Melanoma Growth and Lung Metastasis.

Hong Zhu1, Zhenquan Jia2, Michael A Trush3, Y Robert Li1,2,4,5.   

Abstract

The role of Nrf2, a key regulator of antioxidant and cytoprotective genes, in tumorigenesis remains controversial. Here we showed that Nrf2 deficiency led to increased local tumor growth in mice following subcutaneous injection of B16-F10 melanoma cells, as indicated by increased proportion of animals with locally palpable tumor mass and time-dependent increases in tumor volume at the injection site. In vivo bioluminescence imaging also revealed increased growth of melanoma in Nrf2-null mice as compared with wild-type mice. By using a highly sensitive bioluminometric assay, we further found that Nrf2 deficiency resulted in a remarkable increase in lung metastasis of B16-F10 melanoma cells as compared with wild-type mice. Taken together, the results of this short communication for the first time demonstrated that Nrf2 deficiency promoted melanoma growth and lung metastasis following subcutaneous inoculation of B16-F10 cells in mice.

Entities:  

Keywords:  B16-F10 cells; Bioluminescence imaging; Bioluminometry; Lung metastasis; Melanoma; Nrf2

Year:  2016        PMID: 29721548      PMCID: PMC5926243          DOI: 10.20455/ros.2016.853

Source DB:  PubMed          Journal:  React Oxyg Species (Apex)


  19 in total

1.  Nivolumab in previously untreated melanoma without BRAF mutation.

Authors:  Caroline Robert; Georgina V Long; Benjamin Brady; Caroline Dutriaux; Michele Maio; Laurent Mortier; Jessica C Hassel; Piotr Rutkowski; Catriona McNeil; Ewa Kalinka-Warzocha; Kerry J Savage; Micaela M Hernberg; Celeste Lebbé; Julie Charles; Catalin Mihalcioiu; Vanna Chiarion-Sileni; Cornelia Mauch; Francesco Cognetti; Ana Arance; Henrik Schmidt; Dirk Schadendorf; Helen Gogas; Lotta Lundgren-Eriksson; Christine Horak; Brian Sharkey; Ian M Waxman; Victoria Atkinson; Paolo A Ascierto
Journal:  N Engl J Med       Date:  2014-11-16       Impact factor: 91.245

2.  Mutant MHC class II epitopes drive therapeutic immune responses to cancer.

Authors:  Sebastian Kreiter; Mathias Vormehr; Niels van de Roemer; Mustafa Diken; Martin Löwer; Jan Diekmann; Sebastian Boegel; Barbara Schrörs; Fulvia Vascotto; John C Castle; Arbel D Tadmor; Stephen P Schoenberger; Christoph Huber; Özlem Türeci; Ugur Sahin
Journal:  Nature       Date:  2015-04-22       Impact factor: 49.962

3.  Rapid eradication of a bulky melanoma mass with one dose of immunotherapy.

Authors:  Paul B Chapman; Sandra P D'Angelo; Jedd D Wolchok
Journal:  N Engl J Med       Date:  2015-04-20       Impact factor: 91.245

4.  T cell metabolism. The protein LEM promotes CD8⁺ T cell immunity through effects on mitochondrial respiration.

Authors:  Isobel Okoye; Lihui Wang; Katharina Pallmer; Kirsten Richter; Takahuru Ichimura; Robert Haas; Josh Crouse; Onjee Choi; Dean Heathcote; Elena Lovo; Claudio Mauro; Reza Abdi; Annette Oxenius; Sophie Rutschmann; Philip G Ashton-Rickardt
Journal:  Science       Date:  2015-04-16       Impact factor: 47.728

5.  Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice.

Authors:  M Ramos-Gomez; M K Kwak; P M Dolan; K Itoh; M Yamamoto; P Talalay; T W Kensler
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

6.  Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET.

Authors:  Héctor Peinado; Maša Alečković; Simon Lavotshkin; Irina Matei; Bruno Costa-Silva; Gema Moreno-Bueno; Marta Hergueta-Redondo; Caitlin Williams; Guillermo García-Santos; Cyrus Ghajar; Ayuko Nitadori-Hoshino; Caitlin Hoffman; Karen Badal; Benjamin A Garcia; Margaret K Callahan; Jianda Yuan; Vilma R Martins; Johan Skog; Rosandra N Kaplan; Mary S Brady; Jedd D Wolchok; Paul B Chapman; Yibin Kang; Jacqueline Bromberg; David Lyden
Journal:  Nat Med       Date:  2012-06       Impact factor: 53.440

7.  Enhanced spontaneous and benzo(a)pyrene-induced mutations in the lung of Nrf2-deficient gpt delta mice.

Authors:  Yasunobu Aoki; Akiko H Hashimoto; Kimiko Amanuma; Michi Matsumoto; Kyoko Hiyoshi; Hirohisa Takano; Ken-ichi Masumura; Ken Itoh; Takehiko Nohmi; Masayuki Yamamoto
Journal:  Cancer Res       Date:  2007-06-15       Impact factor: 12.701

8.  NRF2 Intensifies Host Defense Systems to Prevent Lung Carcinogenesis, but After Tumor Initiation Accelerates Malignant Cell Growth.

Authors:  Hironori Satoh; Takashi Moriguchi; Daisuke Saigusa; Liam Baird; Lei Yu; Hirofumi Rokutan; Keiko Igarashi; Masahito Ebina; Tatsuhiro Shibata; Masayuki Yamamoto
Journal:  Cancer Res       Date:  2016-03-28       Impact factor: 12.701

9.  Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells.

Authors:  Yoshihiro Inami; Satoshi Waguri; Ayako Sakamoto; Tsuguka Kouno; Kazuto Nakada; Okio Hino; Sumio Watanabe; Jin Ando; Manabu Iwadate; Masayuki Yamamoto; Myung-Shik Lee; Keiji Tanaka; Masaaki Komatsu
Journal:  J Cell Biol       Date:  2011-04-11       Impact factor: 10.539

10.  Targeted deletion of Nrf2 reduces urethane-induced lung tumor development in mice.

Authors:  Alison K Bauer; Hye-Youn Cho; Laura Miller-Degraff; Christopher Walker; Katherine Helms; Jennifer Fostel; Masayuki Yamamoto; Steven R Kleeberger
Journal:  PLoS One       Date:  2011-10-21       Impact factor: 3.240

View more
  7 in total

1.  A Simple Bioluminescence Imaging Method for Studying Cancer Cell Growth and Metastasis after Subcutaneous Injection of Lewis Lung Carcinoma Cells in Syngeneic C57BL/6 Mice.

Authors:  Hong Zhu; Megan E Kauffman; Michael A Trush; Zhenquan Jia; Y Robert Li
Journal:  React Oxyg Species (Apex)       Date:  2018-03

Review 2.  Non-Apoptotic Cell Death Signaling Pathways in Melanoma.

Authors:  Mariusz L Hartman
Journal:  Int J Mol Sci       Date:  2020-04-23       Impact factor: 5.923

Review 3.  ROS Pleiotropy in Melanoma and Local Therapy with Physical Modalities.

Authors:  Sanjeev Kumar Sagwal; Sander Bekeschus
Journal:  Oxid Med Cell Longev       Date:  2021-11-03       Impact factor: 6.543

Review 4.  Tumor-Derived Exosomes Modulate Primary Site Tumor Metastasis.

Authors:  Suwen Bai; Zunyun Wang; Minghua Wang; Junai Li; Yuan Wei; Ruihuan Xu; Juan Du
Journal:  Front Cell Dev Biol       Date:  2022-03-02

5.  Anthocyanins from Hibiscus syriacus L. Inhibit Oxidative Stress-Mediated Apoptosis by Activating the Nrf2/HO-1 Signaling Pathway.

Authors:  Ilandarage Menu Neelaka Molagoda; Kyoung Tae Lee; Yung Hyun Choi; Gi-Young Kim
Journal:  Antioxidants (Basel)       Date:  2020-01-03

Review 6.  Oxidative Stress-Related Mechanisms in Melanoma and in the Acquired Resistance to Targeted Therapies.

Authors:  Stefania Pizzimenti; Simone Ribero; Marie Angele Cucci; Margherita Grattarola; Chiara Monge; Chiara Dianzani; Giuseppina Barrera; Giuliana Muzio
Journal:  Antioxidants (Basel)       Date:  2021-12-03

Review 7.  NRF2 and Key Transcriptional Targets in Melanoma Redox Manipulation.

Authors:  Evan L Carpenter; Alyssa L Becker; Arup K Indra
Journal:  Cancers (Basel)       Date:  2022-03-16       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.